VDJ-032

N/A

Report date: 2025/06/09 17:26:47

Base Information

Drug NameVDJ-032
Drug Alias NameVDJ032VDJ-032
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInterleukin-6 receptor subunit beta modulatorsTumor necrosis factor superfamily member 15 modulators
TargetsInterleukin-6 receptor subunit betaTumor necrosis factor superfamily member 15
Therapy Area/IndicationsAtherosclerosisRenal Insufficiency, ChronicGraves Ophthalmopathy +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Vdjbio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Vdjbio Co Ltd
Inactive CompaniesN/A
Active IndicationsAtherosclerosisRenal Insufficiency, ChronicGraves Ophthalmopathy +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A